$ASII
Accredited Solutions, Inc.

2022 Q4 Form 10-Q Financial Statement

#000147793222008831 Filed on November 22, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3
Revenue $206.5K $416.3K
YoY Change -50.39% 308.12%
Cost Of Revenue $169.0K $408.8K
YoY Change -58.66% 426.15%
Gross Profit $37.54K $7.570K
YoY Change 395.87% -68.88%
Gross Profit Margin 18.18% 1.82%
Selling, General & Admin $128.3K
YoY Change
% of Gross Profit 341.66%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $7.080K $420.3K
YoY Change -98.32%
% of Gross Profit 18.86% 5552.71%
Operating Expenses $135.3K $651.0K
YoY Change -79.21% 123.77%
Operating Profit -$97.79K -$643.4K
YoY Change -84.8% 141.35%
Interest Expense $149.3K $103.3K
YoY Change 44.6% 3134.87%
% of Operating Profit
Other Income/Expense, Net $581.2K -$1.193M
YoY Change -148.71% -1122.78%
Pretax Income $483.4K $6.793K
YoY Change 7016.3%
Income Tax
% Of Pretax Income
Net Earnings $483.4K -$1.857M
YoY Change -126.03% 1138.42%
Net Earnings / Revenue 234.08% -446.03%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 -$81.33K
COMMON SHARES
Basic Shares Outstanding 282.7M shares 221.1M shares 23.44M shares
Diluted Shares Outstanding 659.5M shares 102.5M shares

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $132.8K $13.41K
YoY Change 890.45% -64.48%
Cash & Equivalents $35.97K $132.8K $13.41K
Short-Term Investments
Other Short-Term Assets $16.78K $167.2K
YoY Change -89.97% 28.04%
Inventory $0.00 $1.966K $0.00
Prepaid Expenses $2.422K $16.78K $166.9K
Receivables $51.22K $20.85K $64.80K
Other Receivables $0.00 $0.00
Total Short-Term Assets $321.3K $172.4K $245.5K
YoY Change 1349.19% -29.76% -29.58%
LONG-TERM ASSETS
Property, Plant & Equipment $86.45K $101.8K $130.1K
YoY Change -29.71% -21.77%
Goodwill $302.2K $302.2K $563.5K
YoY Change 0.0% -46.37%
Intangibles $105.0K $112.0K $12.00K
YoY Change -6.25% 833.33%
Long-Term Investments $66.99K
YoY Change 5.61%
Other Assets
YoY Change
Total Long-Term Assets $493.7K $516.0K $772.6K
YoY Change -33.21% -72.16%
TOTAL ASSETS
Total Short-Term Assets $321.3K $172.4K $245.5K
Total Long-Term Assets $493.7K $516.0K $772.6K
Total Assets $815.0K $688.4K $1.018M
YoY Change 3575.7% -32.38% -67.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $104.9K $87.98K $84.63K
YoY Change 33.31% 3.96% -41.67%
Accrued Expenses $3.751K $5.064K $128.1K
YoY Change -59.25% -96.05% 287.98%
Deferred Revenue
YoY Change
Short-Term Debt $995.4K $1.563M
YoY Change -36.33% 121.27%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.690M $2.343M $6.523M
YoY Change -8.3% -64.08% 113.27%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $4.690M $2.343M $6.523M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $4.690M $2.343M $6.523M
YoY Change -8.3% -64.08% 113.27%
SHAREHOLDERS EQUITY
Retained Earnings -$6.385M -$4.018M -$14.11M
YoY Change 15962600.0% -71.53%
Common Stock $339.3K $269.7K $23.45K
YoY Change 231.0% 1050.23%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$3.875M -$1.654M -$5.505M
YoY Change
Total Liabilities & Shareholders Equity $815.0K $688.4K $1.018M
YoY Change 3575.7% -32.38% -67.41%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income $483.4K -$1.857M
YoY Change -126.03% 1138.42%
Depreciation, Depletion And Amortization $7.080K $420.3K
YoY Change -98.32%
Cash From Operating Activities -$96.01K -$281.3K
YoY Change -65.87% -418.54%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 125.0K 189.7K
YoY Change -34.11% -314.82%
NET CHANGE
Cash From Operating Activities -96.01K -281.3K
Cash From Investing Activities 0.000 0.000
Cash From Financing Activities 125.0K 189.7K
Net Change In Cash 28.99K -91.59K
YoY Change -131.65% 39337605464063990.0%
FREE CASH FLOW
Cash From Operating Activities -$96.01K -$281.3K
Capital Expenditures $0.00
Free Cash Flow -$281.3K
YoY Change -418.54%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
30000000 shares
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000 shares
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5064 usd
CY2022Q3 us-gaap Interest Payable Current
InterestPayableCurrent
38187 usd
CY2022Q3 ghmp Interest Payable To Related Parties
InterestPayableToRelatedParties
134581 usd
CY2022Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
556331 usd
CY2022Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
1081627 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
2342869 usd
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
102500000 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
269671 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
102500 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2093569 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
-80288 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-4017726 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-40 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-1654486 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
22172 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
688383 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
22172 usd
CY2022Q3 us-gaap Revenues
Revenues
206520 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
128252 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
135331 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-97794 usd
CY2022Q3 us-gaap Legal Fees
LegalFees
3996 usd
CY2022Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-367359 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
581208 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
483414 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
0 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2021Q3 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
102500000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
659486500 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
102500000 shares
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
84070
dei City Area Code
CityAreaCode
1-800
dei Entity Central Index Key
EntityCentralIndexKey
0001464865
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
30000000 shares
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
269670577 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
102500000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Registrant Name
EntityRegistrantName
ACCREDITED SOLUTIONS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity File Number
EntityFileNumber
000-54509
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
45-2578051
dei Entity Address Address Line1
EntityAddressAddressLine1
9980 South 300 West
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 200
dei Entity Shell Company
EntityShellCompany
false
dei Entity Address City Or Town
EntityAddressCityOrTown
Sandy
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
282656620 shares
dei Entity Address State Or Province
EntityAddressStateOrProvince
UT
dei Local Phone Number
LocalPhoneNumber
947-9197
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021Q4 ghmp Interest Payable To Related Parties
InterestPayableToRelatedParties
0 usd
CY2022Q3 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
29100 usd
CY2021Q4 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
0 usd
CY2022Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
410000 usd
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
0 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
0 usd
CY2022Q3 us-gaap Liabilities
Liabilities
2342869 usd
CY2021Q4 us-gaap Liabilities
Liabilities
0 usd
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
269670577 shares
us-gaap Revenues
Revenues
0 usd
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
0 usd
us-gaap Gross Profit
GrossProfit
68723 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
30 usd
CY2021Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
0 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
10933 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
0 usd
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
0 usd
us-gaap Operating Expenses
OperatingExpenses
220346 usd
us-gaap Operating Expenses
OperatingExpenses
30 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
0 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-151623 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-30 usd
CY2021Q3 us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
0 usd
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
814563668 shares
us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
3890256 usd
us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
0 usd
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2022Q3 us-gaap Interest Expense
InterestExpense
149307 usd
CY2021Q3 us-gaap Interest Expense
InterestExpense
0 usd
CY2022Q3 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
225222172 shares
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
155077168 shares
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
101274725 shares
us-gaap Interest Expense
InterestExpense
320882 usd
us-gaap Interest Expense
InterestExpense
0 usd
CY2021Q3 us-gaap Legal Fees
LegalFees
0 usd
us-gaap Legal Fees
LegalFees
13806 usd
us-gaap Legal Fees
LegalFees
0 usd
CY2021Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1068278 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
us-gaap Increase Decrease Due From Other Related Parties
IncreaseDecreaseDueFromOtherRelatedParties
13616 usd
us-gaap Increase Decrease Due From Other Related Parties
IncreaseDecreaseDueFromOtherRelatedParties
0 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2487290 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
us-gaap Net Income Loss
NetIncomeLoss
2335667 usd
us-gaap Net Income Loss
NetIncomeLoss
-30 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
101274725 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
22172 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-2816 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
19356 usd
CY2022Q2 ghmp Issuance Of Common Stock For Cash Amount
IssuanceOfCommonStockForCashAmount
120000 usd
CY2022Q2 ghmp Cancellation Of Common Stock Amount
CancellationOfCommonStockAmount
0 usd
CY2022Q2 ghmp Reverse Merger Acquisition Amount
ReverseMergerAcquisitionAmount
-6216463 usd
CY2022Q2 ghmp Issuance Of Common Stock For Conversion Of Note Payable Amount
IssuanceOfCommonStockForConversionOfNotePayableAmount
1252340 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
1855069 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-2969698 usd
CY2022Q3 ghmp Issuance Of Common Stock For Conversion Of Note Payable Amount
IssuanceOfCommonStockForConversionOfNotePayableAmount
831798 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
483414 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-1654486 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
2202 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-15 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
2187 usd
CY2021Q2 ghmp Issuance Of Common Stock For Cash Amount
IssuanceOfCommonStockForCashAmount
10000 usd
CY2021Q2 ghmp Issuance Of Common Stock For Exercise Of Warrant Amount
IssuanceOfCommonStockForExerciseOfWarrantAmount
10000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-15 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
22172 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
0 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
22172 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
2335667 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-30 usd
us-gaap Depreciation
Depreciation
10933 usd
us-gaap Depreciation
Depreciation
0 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
183036 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
0 usd
ghmp Gains Loss On Extinguishment Of Debt
GainsLossOnExtinguishmentOfDebt
1068278 usd
ghmp Gains Loss On Extinguishment Of Debt
GainsLossOnExtinguishmentOfDebt
0 usd
ghmp Gain Loss On Sales Of Derivatives
GainLossOnSalesOfDerivatives
-3890256 usd
ghmp Gain Loss On Sales Of Derivatives
GainLossOnSalesOfDerivatives
0 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-17305 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
0 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
22642 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
0 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-13239 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
0 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
6597 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
0 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-322 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
0 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
133679 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
0 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-146674 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-30 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
125000 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
120000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
20000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
245000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
20000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
98326 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
19970 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
34494 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
190 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
132820 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
20160 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
883 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
2084138 usd
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
0 usd
us-gaap Nature Of Operations
NatureOfOperations
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NOTE 1 – NATURE OF OPERATIONS</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Accredited Solutions, Inc. (the “Company” or “Accredited Solutions”), formerly known as Good Hemp, Inc., Keyser Resources, Inc., and Lone Star Gold, Inc., was incorporated in the State of Nevada on November 26, 2007.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company was involved in the exploration and development of mining properties until September 30, 2013, when it discontinued operations. On February 6, 2019, the Company acquired trademarks and intellectual property, which included all rights and trade secrets to the hemp-derived CBD-infused line of consumer beverages sold under the “Good Hemp” brand, and the Company subsequently changed its name to “Good Hemp, Inc.” in September of 2019. On April 2, 2021, the Company acquired Diamond Creek Group, LLC, a North Carolina limited liability company, which sells the Diamond Creek brand of high alkaline water products.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On March 8, 2022, the Company entered into a plan and agreement of merger with Petro X Solutions, Inc., a Wyoming corporation (“Petro X Solutions”), which markets EnviroXstreamTM cleaner/degreaser and other competitively-priced, environmentally-friendly products that are designed to work as well as or better than their toxic competitors, for an aggregate of 100,000,000 shares of Company common stock. On May 11, 2022, the Company closed this transaction, Petro X Solutions became a wholly-owned subsidiary of the Company, and 100,000,000 shares of common stock were authorized for issuance to Petro X Solutions’s pre-closing shareholders. 20,000,000 of such shares were issued to the Petro X Solutions shareholders, the balance of the 100,000,000 issuable shares being issued in August 2022, the Company’s then-CEO and then-directors resigned, and new officers and directors were appointed, constituting a change of control of the Company.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On July 12, 2022, the Company changed its name from “Good Hemp, Inc.” to “Accredited Solutions, Inc.” as it is no longer only focused on selling hemp beverages. The Company is now focused primarily on selling (i) high alkaline water products under the “Diamond Creek” brand name, and (i) the EnviroXstream<sup style="vertical-align:super">TM </sup>cleaner/degreaser and other competitively-priced, environmentally-friendly products that are designed to work as well as or better than their toxic competitors.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We may experience impact from quarantines, market downturns and changes in customer behavior related to pandemic fears and impact on our workforce if the virus continues to spread. In addition, one or more of our customers, partners, service providers or suppliers may experience financial distress, delayed or defaults on payment, file for bankruptcy protection, sharp diminishing of business, or suffer disruptions in their business due to the outbreak. The extent to which the coronavirus impacts our results will depend on future developments and reactions throughout the world, which are highly uncertain and will include emerging information concerning the severity of the coronavirus and the actions taken by governments and private businesses to attempt to contain the coronavirus. It is likely to result in a potential material adverse impact on our business, results of operations and financial condition. Wider-spread COVID-19 globally could prolong the deterioration in economic conditions and could cause decreases in or delays in advertising spending and reduce and/or negatively impact our short-term ability to grow our revenues. Any decreased collectability of accounts receivable, bankruptcy of small and medium businesses, or early termination of agreements due to deterioration in economic conditions could negatively impact our results of operations.</p>
ghmp Description Agreement Of Merger With Petro X Solutions Inc
DescriptionAgreementOfMergerWithPetroXSolutionsInc
a Wyoming corporation (“Petro X Solutions”), which markets EnviroXstreamTM cleaner/degreaser and other competitively-priced, environmentally-friendly products that are designed to work as well as or better than their toxic competitors, for an aggregate of 100,000,000 shares of Company common stock. On May 11, 2022, the Company closed this transaction, Petro X Solutions became a wholly-owned subsidiary of the Company, and 100,000,000 shares of common stock were authorized for issuance to Petro X Solutions’s pre-closing shareholders
ghmp Condensed Financial Statementspolicytextblock
CondensedFinancialStatementspolicytextblock
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The unaudited condensed financial statements of the Company for the nine month periods ended September 30, 2022 and 2021 have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and pursuant to the requirements for reporting on Form 10-Q and Regulation S-K. Accordingly, they do not include all the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. However, such information reflects all adjustments (consisting solely of normal recurring adjustments), which are, in the opinion of management, necessary for the fair presentation of the financial position and the results of operations. Results shown for interim periods are not necessarily indicative of the results to be obtained for a full fiscal year. The balance sheet information as of December 31, 2021 was derived from the audited financial statements included in the Company’s financial statements as of and for the year ended December 31, 2021 included in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission (the “SEC”) on April 25, 2022. These unaudited condensed financial statements should be read in conjunction with that report.</p>
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to the recoverability of long-lived assets and deferred income tax asset valuation allowances. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.</p>
CY2022Q3 ghmp Working Capital Deficit
WorkingCapitalDeficit
-2170455 usd
us-gaap Profit Loss
ProfitLoss
2335667 usd
CY2022Q2 ghmp Class A Preferred Shares Forl Value
ClassAPreferredSharesForlValue
12000 usd
CY2019Q2 ghmp Related Inventory Consideration
RelatedInventoryConsideration
32462 usd
ghmp Initial Portion Of Purchase Price Paid
InitialPortionOfPurchasePricePaid
643000 usd
CY2021Q2 ghmp Initial Portion Of Purchase Price Paid
InitialPortionOfPurchasePricePaid
500000 usd
CY2021Q2 ghmp Initial Portion Of Purchase Price Paid
InitialPortionOfPurchasePricePaid
143000 usd
CY2022Q3 us-gaap Business Acquisition Cost Of Acquired Entity Transaction Costs
BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
643000 usd
CY2022Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
38635 usd
CY2022Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Receivables
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
41611 usd
CY2022Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
97228 usd
CY2022Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
100000 usd
CY2022Q3 ghmp Assets Acquired
AssetsAcquired
277474 usd
CY2022Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
77998 usd
CY2022Q3 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
20000 usd
CY2022Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
97998 usd
CY2022Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
463524 usd
CY2022Q3 us-gaap Business Acquisition Purchase Price Allocation Goodwill Expected Tax Deductible Amount
BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
161309 usd
CY2022Q3 us-gaap Goodwill
Goodwill
302215 usd
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
100000000 shares
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
ghmp Schedule Of Summary Purchases Towards Related Party
ScheduleOfSummaryPurchasesTowardsRelatedParty
<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Name Officer/Director</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Number of Shares</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Ron F. Sickels (1)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">28,333,333</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Fabian G. Deneault</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">28,333,333</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">William E. Sluss</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">10,000,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Eric Newlan</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">14,416,667</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
us-gaap Schedule Of Repurchase Agreements
ScheduleOfRepurchaseAgreements
<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Class A</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Name</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Preferred</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Shares</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Consideration</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">William Alessi</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">12,000,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">200,000</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><sup style="vertical-align:super">(1)</sup></p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Chris Chumas</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">6,000,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">100,000</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><sup style="vertical-align:super">(1)</sup> </p></td></tr></tbody></table>
CY2019Q3 us-gaap Contingent Consideration Classified As Equity Fair Value Disclosure
ContingentConsiderationClassifiedAsEquityFairValueDisclosure
100000 usd
CY2022Q4 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.08 pure
CY2022Q3 ghmp Total
Total
410000 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P1Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
4.598 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.07 pure
CY2022Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
1081627 usd
CY2021Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
3220927 usd
CY2022Q3 ghmp Number Of Shares Authorised Increased
NumberOfSharesAuthorisedIncreased
750000000 shares

Files In Submission

Name View Source Status
0001477932-22-008831-index-headers.html Edgar Link pending
0001477932-22-008831-index.html Edgar Link pending
0001477932-22-008831.txt Edgar Link pending
0001477932-22-008831-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
ghmp-20220930.xsd Edgar Link pending
ghmp_10q.htm Edgar Link pending
ghmp_ex311.htm Edgar Link pending
ghmp_ex312.htm Edgar Link pending
ghmp_ex321.htm Edgar Link pending
ghmp_ex322.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
ghmp-20220930_cal.xml Edgar Link unprocessable
ghmp-20220930_def.xml Edgar Link unprocessable
ghmp-20220930_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
ghmp-20220930_pre.xml Edgar Link unprocessable
ghmp_10q_htm.xml Edgar Link completed
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending